[Angioendotheliomatosis proliferans systematizata]

Area of Science:

• Vascular pathology
• Hematologic oncology
• Dermatology

Background:

• Angioendotheliomatosis proliferans systematisata encompasses two distinct conditions: a malignant form and a benign reactive form.
• The malignant variant, intravascular or angiotropic lymphoma, is a systemic disease with a poor prognosis, primarily affecting blood vessels in the skin and central nervous system.
• Reactive angioendotheliomatosis is a benign condition frequently linked to infections, particularly subacute bacterial endocarditis.

Observation:

• This report details a 38-year-old female patient diagnosed with reactive angioendotheliomatosis.
• A 68-year-old male patient was diagnosed with a rare T-cell type of intravascular lymphoma.

Findings:

• The study differentiates between the fatal malignant intravascular lymphoma and the benign reactive angioendotheliomatosis.
• It presents clinical cases illustrating both entities, emphasizing their distinct characteristics and associations.
• The rare T-cell variant of intravascular lymphoma is specifically noted.

Implications:

• Accurate differentiation between malignant and reactive angioendotheliomatosis is crucial for appropriate patient management and prognosis.
• Understanding the diverse presentations of angioendotheliomatosis aids in diagnosing rare conditions like T-cell intravascular lymphoma.
• This work contributes to the literature on vascular proliferative disorders and their associated hematologic malignancies.